Ruben Goedegebuure

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

Niet-gemetastaseerde slokdarmkanker

Voeten, D. M., den Bakker, C. M., Goedegebuure, R. S. A., Heineman, D. J., Daams, F. & van der Peet, D. L., 2019, In : Nederlands Tijdschrift voor Geneeskunde. 163, 39, D3718.

Research output: Contribution to journalArticleProfessional

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

Huijts, C. M., Werter, I. M., Lougheed, S. M., Goedegebuure, R. S., van Herpen, C. M., Hamberg, P., Tascilar, M., Haanen, J. B., Verheul, H. M., de Gruijl, T. D., van der Vliet, H. J. & Dutch WIN-O Consortium, Feb 2019, In : Cancer Immunology, Immunotherapy. 68, 2, p. 319-329

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Goedegebuure, R. S. A., de Klerk, L. K., Bass, A. J., Derks, S. & Thijssen, V. L. J. L., 2018, In : Frontiers in Immunology. 9, p. 3107

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access